156 related articles for article (PubMed ID: 25542695)
1. The bone marrow microenvironment is a critical player in the NK cell response against acute myeloid leukaemia in vitro.
Vasold J; Wagner M; Drolle H; Deniffel C; Kütt A; Oostendorp R; Sironi S; Rieger C; Fiegl M
Leuk Res; 2015 Feb; 39(2):257-62. PubMed ID: 25542695
[TBL] [Abstract][Full Text] [Related]
2. Natural killer cells adhere to bone marrow fibroblasts and inhibit adhesion of acute myeloid leukemia cells.
Bendall LJ; Kortlepel K; Bradstock KF; Gottlieb DJ
Leukemia; 1995 Jun; 9(6):999-1005. PubMed ID: 7596192
[TBL] [Abstract][Full Text] [Related]
3. IL-8 as mediator in the microenvironment-leukaemia network in acute myeloid leukaemia.
Kuett A; Rieger C; Perathoner D; Herold T; Wagner M; Sironi S; Sotlar K; Horny HP; Deniffel C; Drolle H; Fiegl M
Sci Rep; 2015 Dec; 5():18411. PubMed ID: 26674118
[TBL] [Abstract][Full Text] [Related]
4. Acute myeloid leukaemia cells secrete a soluble factor that inhibits T and NK cell proliferation but not cytolytic function--implications for the adoptive immunotherapy of leukaemia.
Orleans-Lindsay JK; Barber LD; Prentice HG; Lowdell MW
Clin Exp Immunol; 2001 Dec; 126(3):403-11. PubMed ID: 11737054
[TBL] [Abstract][Full Text] [Related]
5. Activated natural killer cells from patients with acute myeloid leukemia are cytotoxic against autologous leukemic blasts in NOD/SCID mice.
Siegler U; Kalberer CP; Nowbakht P; Sendelov S; Meyer-Monard S; Wodnar-Filipowicz A
Leukemia; 2005 Dec; 19(12):2215-22. PubMed ID: 16224486
[TBL] [Abstract][Full Text] [Related]
6. NK cells play a significant role in immunosurveillance at the early stage of MLL-AF9 acute myeloid leukemia via CD226/CD155 interactions.
Wang Y; Chen C; Dong F; Ma S; Xu J; Gong Y; Cheng H; Zhou Y; Cheng T; Hao S
Sci China Life Sci; 2015 Dec; 58(12):1288-98. PubMed ID: 26588911
[TBL] [Abstract][Full Text] [Related]
7. Characteristics of NK cells from leukemic microenvironment in MLL-AF9 induced acute myeloid leukemia.
Yang F; Wang R; Feng W; Chen C; Yang X; Wang L; Hu Y; Ren Q; Zheng G
Mol Immunol; 2018 Jan; 93():68-78. PubMed ID: 29154208
[TBL] [Abstract][Full Text] [Related]
8. Acute myeloid leukemic cell lines loaded with synthetic dsRNA trigger IFN-gamma secretion by human NK cells.
Lion E; Smits EL; Berneman ZN; Van Tendeloo VF
Leuk Res; 2009 Apr; 33(4):539-46. PubMed ID: 18845337
[TBL] [Abstract][Full Text] [Related]
9. Antileukemia activity of a natural killer cell line against human leukemias.
Yan Y; Steinherz P; Klingemann HG; Dennig D; Childs BH; McGuirk J; O'Reilly RJ
Clin Cancer Res; 1998 Nov; 4(11):2859-68. PubMed ID: 9829753
[TBL] [Abstract][Full Text] [Related]
10. TLR4 plays a crucial role in MSC-induced inhibition of NK cell function.
Lu Y; Liu J; Liu Y; Qin Y; Luo Q; Wang Q; Duan H
Biochem Biophys Res Commun; 2015 Aug; 464(2):541-7. PubMed ID: 26159925
[TBL] [Abstract][Full Text] [Related]
11. c-Myc plays part in drug resistance mediated by bone marrow stromal cells in acute myeloid leukemia.
Xia B; Tian C; Guo S; Zhang L; Zhao D; Qu F; Zhao W; Wang Y; Wu X; Da W; Wei S; Zhang Y
Leuk Res; 2015 Jan; 39(1):92-9. PubMed ID: 25443862
[TBL] [Abstract][Full Text] [Related]
12. Multiple Myeloma Impairs Bone Marrow Localization of Effector Natural Killer Cells by Altering the Chemokine Microenvironment.
Ponzetta A; Benigni G; Antonangeli F; Sciumè G; Sanseviero E; Zingoni A; Ricciardi MR; Petrucci MT; Santoni A; Bernardini G
Cancer Res; 2015 Nov; 75(22):4766-77. PubMed ID: 26438594
[TBL] [Abstract][Full Text] [Related]
13. Mesenchymal stem cells derived from low risk acute lymphoblastic leukemia patients promote NK cell antitumor activity.
Entrena A; Varas A; Vázquez M; Melen GJ; Fernández-Sevilla LM; García-Castro J; Ramírez M; Zapata AG; Vicente Á
Cancer Lett; 2015 Jul; 363(2):156-65. PubMed ID: 25917077
[TBL] [Abstract][Full Text] [Related]
14. Lysis of fresh leukemic blasts by interferon-activated human natural killer cells.
Pattengale PK; Sundstrom C; Yu AL; Levine A
Nat Immun Cell Growth Regul; 1983-1984; 3(4):165-80. PubMed ID: 6597341
[TBL] [Abstract][Full Text] [Related]
15. Generation of highly cytotoxic natural killer cells for treatment of acute myelogenous leukemia using a feeder-free, particle-based approach.
Oyer JL; Igarashi RY; Kulikowski AR; Colosimo DA; Solh MM; Zakari A; Khaled YA; Altomare DA; Copik AJ
Biol Blood Marrow Transplant; 2015 Apr; 21(4):632-9. PubMed ID: 25576425
[TBL] [Abstract][Full Text] [Related]
16. Hypoxia regulates proliferation of acute myeloid leukemia and sensitivity against chemotherapy.
Drolle H; Wagner M; Vasold J; Kütt A; Deniffel C; Sotlar K; Sironi S; Herold T; Rieger C; Fiegl M
Leuk Res; 2015 Jul; 39(7):779-85. PubMed ID: 25982178
[TBL] [Abstract][Full Text] [Related]
17. Acute myeloid leukemia impairs natural killer cells through the formation of a deficient cytotoxic immunological synapse.
Khaznadar Z; Henry G; Setterblad N; Agaugue S; Raffoux E; Boissel N; Dombret H; Toubert A; Dulphy N
Eur J Immunol; 2014 Oct; 44(10):3068-80. PubMed ID: 25041786
[TBL] [Abstract][Full Text] [Related]
18. The bone marrow microenvironment - Home of the leukemic blasts.
Shafat MS; Gnaneswaran B; Bowles KM; Rushworth SA
Blood Rev; 2017 Sep; 31(5):277-286. PubMed ID: 28318761
[TBL] [Abstract][Full Text] [Related]
19. Natural killer cell immune escape in acute myeloid leukemia.
Lion E; Willemen Y; Berneman ZN; Van Tendeloo VF; Smits EL
Leukemia; 2012 Sep; 26(9):2019-26. PubMed ID: 22446501
[TBL] [Abstract][Full Text] [Related]
20. A novel nonradioactive CFDA assay to monitor the cellular immune response in myeloid leukemia.
Yang T; Chen ZZ; Kolb HJ; Buhmann R
Immunobiology; 2013 Apr; 218(4):548-53. PubMed ID: 22883564
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
